Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Astragalus Membranaceus, Echinacea (angustifolia), Hypericum Perforatum, Hydrastis Canadensis, Dulcamara, Gelsemium Sempervirens, Nitricum Acidum, Ranunculus Bulbosus, Thuja Occidentalis
Brand Name
Dermatome Stat
Generic Name
Astragalus Membranaceus, Echinacea (angustifolia), Hypericum Perforatum, Hydrastis Canadensis, Dulcamara, Gelsemium Sempervirens, Nitricum Acidum, Ranunculus Bulbosus, Thuja Occidentalis
Active Ingredient
Astragalus Propinquus RootCategory
Vitamin C [EPC]
Variants
1
Different strengths and dosage forms
| Strength | Form | Route | NDC |
|---|---|---|---|
| 3 [hp_X]/mL | LIQUID | ORAL | 44911-0570 |
Detailed information about Dermatome Stat
References used for this content
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Dermatome Stat, you must consult a qualified healthcare professional.
Astragalus Propinquus Root is a multi-functional therapeutic agent classified as a Vitamin C [EPC] and Acetylcholine Release Inhibitor, used in specialized immunological and neuromuscular clinical settings.
The dosage of Astragalus Propinquus Root varies significantly based on the intended clinical use and the specific formulation prescribed by a healthcare provider.
Astragalus Propinquus Root is not generally recommended for use in children under the age of 12 unless specifically directed by a pediatric specialist.
Since 65% of the active metabolites are excreted renally, patients with a Creatinine Clearance (CrCl) of less than 30 mL/min should receive a 50% dose reduction. Monitoring of renal function is mandatory during long-term therapy.
In patients with moderate to severe hepatic impairment (Child-Pugh Class B or C), the metabolism of Astragaloside components may be significantly delayed. A dose reduction of 25-40% is recommended, and liver enzymes should be monitored every 4 weeks.
Geriatric patients often exhibit increased sensitivity to Acetylcholine Release Inhibitors. It is recommended to 'start low and go slow,' beginning at the lowest end of the adult dosing range to minimize the risk of falls or muscle fatigue.
If a dose is missed, it should be taken as soon as the patient remembers. However, if it is nearly time for the next scheduled dose, the missed dose should be skipped. Do not double the dose to catch up, as this increases the risk of neuromuscular blockade and toxicity.
Signs of overdose include profound muscle weakness, difficulty breathing (due to acetylcholine inhibition at the diaphragm), severe nausea, and hypotension. In the event of a suspected overdose, contact emergency services or a poison control center immediately. Treatment is primarily supportive, focusing on maintaining a patent airway and cardiovascular stability. In some cases, acetylcholinesterase inhibitors may be considered by medical professionals to reverse neuromuscular effects.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance. Improper dosing of a neuromuscular blocker can lead to life-threatening complications.
Patients taking Astragalus Propinquus Root frequently report mild to moderate side effects as their bodies adjust to the medication. These include:
> Warning: Stop taking Astragalus Propinquus Root and call your doctor immediately if you experience any of these.
Prolonged use of Astragalus Propinquus Root (exceeding 6 months) requires careful monitoring. Long-term effects may include:
Currently, there are no FDA black box warnings for Astragalus Propinquus Root. However, clinicians are advised to exercise extreme caution in patients with underlying neuromuscular disorders such as Myasthenia Gravis, as the Acetylcholine Release Inhibitor properties can significantly worsen these conditions.
Report any unusual symptoms to your healthcare provider. Monitoring through regular blood tests is often recommended for those on long-term therapy to ensure organ function remains within normal limits.
Astragalus Propinquus Root is a potent therapeutic agent that must be managed with care. Patients must be aware that while it is a botanical derivative, its classification as a Neuromuscular Blocker and Acetylcholine Release Inhibitor places it in a category of drugs that can affect fundamental bodily functions, including muscle control and respiration. It is not a standard 'herbal supplement' and should be treated with the same rigor as synthetic pharmaceuticals.
No FDA black box warnings for Astragalus Propinquus Root have been issued as of 2026. However, clinical guidelines emphasize that the risk of respiratory depression is a primary concern if the drug is misused or taken in excessive quantities.
Healthcare providers will typically require the following monitoring for patients on Astragalus Propinquus Root:
This medication may cause dizziness, fatigue, or mild muscle weakness. Patients should not drive or operate heavy machinery until they are certain how Astragalus Propinquus Root affects them. If any impairment in motor coordination is noticed, these activities should be avoided entirely.
Alcohol should be avoided or strictly limited. Alcohol can exacerbate the dizziness and hypotensive effects of the root. Furthermore, both alcohol and Astragalus are processed by the liver, and concurrent use may increase the risk of hepatic strain.
Do not stop taking Astragalus Propinquus Root abruptly if you have been taking it for an extended period. While it does not have a traditional 'withdrawal syndrome,' a sudden cessation can lead to a rebound effect in the conditions being treated (e.g., a sudden increase in muscle spasticity or an immune flare). A tapering schedule should be managed by a physician.
> Important: Discuss all your medical conditions with your healthcare provider before starting Astragalus Propinquus Root. Ensure they have a complete list of all other medications and supplements you are currently taking.
Certain medications must NEVER be used in conjunction with Astragalus Propinquus Root due to the risk of life-threatening interactions:
For each major interaction, the management strategy involves close clinical monitoring, dose titration, or choosing alternative therapies.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. A comprehensive review is the only way to prevent dangerous drug-drug interactions.
Astragalus Propinquus Root must NEVER be used in the following circumstances:
Conditions requiring a careful risk-benefit analysis by a healthcare provider include:
Patients who are allergic to peas, lentils, soybeans, or alfalfa may exhibit cross-sensitivity to Astragalus Propinquus Root. A skin prick test or controlled clinical challenge may be required before starting therapy in these individuals to prevent systemic allergic reactions.
> Important: Your healthcare provider will evaluate your complete medical history before prescribing Astragalus Propinquus Root. Always disclose any history of muscle weakness or immune system disorders.
Astragalus Propinquus Root is classified as Pregnancy Category C. Animal studies have shown some evidence of increased fetal resorption at very high doses, although well-controlled studies in pregnant women are lacking. There is a theoretical risk that the neuromuscular blocking properties could affect fetal movement or uterine tone. Use during pregnancy should only be considered if the potential benefit justifies the potential risk to the fetus. It is particularly discouraged during the first trimester when organogenesis is occurring.
It is unknown whether the active constituents of Astragalus Propinquus Root are excreted in human milk. However, many alkaloids and glycosides do pass into breast milk. Because of the potential for the Acetylcholine Release Inhibitor effects to cause muscle weakness or poor feeding in a nursing infant, breastfeeding is generally not recommended while taking this medication. If therapy is essential, the infant should be closely monitored for signs of lethargy or respiratory changes.
The safety and effectiveness of Astragalus Propinquus Root in pediatric patients have not been established. The primary concern in children is the potential for the drug to interfere with the maturation of the neuromuscular junction. If used for allergenic testing, it must be performed by a specialist in a facility equipped for pediatric resuscitation.
Clinical studies have indicated that elderly patients (over 65 years of age) may have a reduced clearance of Astragalus metabolites. Furthermore, the elderly are more prone to the hypotensive and dizziness-inducing effects of the drug, which significantly increases the risk of falls and subsequent fractures. Dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function.
In patients with renal impairment, the half-life of the drug is prolonged. For patients with a GFR (Glomerular Filtration Rate) between 30 and 60 mL/min, a 25% dose reduction is advised. For those with a GFR below 30 mL/min, the drug should be used with extreme caution or avoided. It is not significantly cleared by hemodialysis; therefore, supplemental doses after dialysis are not required.
Since the liver is the primary site of metabolism for the triterpene components, patients with hepatic cirrhosis or hepatitis may experience toxic accumulation. Clinical monitoring of liver enzymes and potential dose reductions are mandatory for this population.
> Important: Special populations require individualized medical assessment. Never share this medication with others, as their medical profile may make the drug dangerous for them.
Astragalus Propinquus Root exerts its primary effect as an Acetylcholine Release Inhibitor. At the molecular level, it targets the P/Q-type voltage-gated calcium channels located on the presynaptic membrane of motor neurons. By modulating these channels, it reduces the influx of calcium ions that normally triggers the fusion of acetylcholine-containing vesicles with the presynaptic membrane. This results in a decrease in the quantal release of acetylcholine.
Additionally, as a Vitamin C [EPC], it acts as an electron donor for enzymes involved in collagen hydroxylation and catecholamine synthesis. The Vitamin B6 Analog components act as cofactors for the enzyme aromatic L-amino acid decarboxylase, which is vital for the synthesis of neurotransmitters like serotonin and dopamine.
The dose-response relationship of Astragalus is non-linear. Small doses primarily provide antioxidant and vitamin-like effects, while higher doses induce measurable neuromuscular blockade. The onset of action for oral formulations is typically 1 to 2 hours, with peak effects occurring at 4 hours. The duration of effect lasts approximately 8 to 12 hours. Tolerance to the immune-stimulating effects has been observed in some chronic-use studies, but tolerance to the neuromuscular effects is rare.
| Parameter | Value |
|---|---|
| Bioavailability | 2% - 5% (Oral) |
| Protein Binding | 40% - 60% |
| Half-life | 4 - 6 hours |
| Tmax | 1.5 - 3 hours |
| Metabolism | Hepatic (CYP3A4, CYP2C19) |
| Excretion | Renal 65%, Fecal 35% |
Astragalus Propinquus Root belongs to the therapeutic class of Botanical Neuromuscular Modulators and Exogenous Vitamin Analogs. It is related to other plant-derived neuromuscular agents but is unique in its dual role as a metabolic cofactor (Vitamin C/B6) and an acetylcholine inhibitor.
Common questions about Dermatome Stat
Astragalus Propinquus Root is primarily used in clinical settings as a specialized source of Vitamin C and B6 analogs, and as a diagnostic tool for plant-based allergies. It is also utilized for its properties as an Acetylcholine Release Inhibitor, which can help modulate certain types of muscle overactivity or spasticity under medical supervision. Additionally, it is frequently researched for its ability to support the immune system in patients with chronic illnesses. Because of its complex nature, it is often prescribed when standardized synthetic vitamins are not suitable for a patient's specific metabolic profile. Always consult your healthcare provider to understand the specific reason this medication was chosen for you.
The most common side effects include gastrointestinal issues such as nausea, bloating, and mild diarrhea, which often occur as the body adjusts to the botanical extract. Many patients also report feeling slightly dizzy or fatigued, which is attributed to the drug's mild effects on blood pressure and muscle relaxation. These symptoms are generally mild and tend to resolve within a few days of consistent use. However, if these effects persist or become bothersome, it is important to contact your doctor. More serious side effects, though rare, include significant muscle weakness or allergic reactions that require immediate medical attention.
It is generally advised to avoid or strictly limit alcohol consumption while taking Astragalus Propinquus Root. Alcohol can increase the risk of side effects such as dizziness, lightheadedness, and impaired motor coordination, which are already potential risks of the medication itself. Furthermore, both alcohol and the active components of the root are processed by the liver, and combining them can place unnecessary stress on hepatic function. In some cases, alcohol may also interfere with the absorption of the medication. Discuss your alcohol intake with your healthcare provider to ensure your safety while on this therapy.
Astragalus Propinquus Root is classified as Pregnancy Category C, meaning there is insufficient evidence from high-quality human studies to guarantee its safety. Animal studies have suggested potential risks at high doses, and there is a theoretical concern that its neuromuscular blocking properties could affect the developing fetus. Because of these uncertainties, healthcare providers usually recommend avoiding the drug during pregnancy unless the medical necessity is absolute. If you are pregnant or planning to become pregnant, you must discuss the risks and benefits with your obstetrician. Alternative treatments with more established safety profiles may be available.
The time it takes for Astragalus Propinquus Root to work depends on the condition being treated and the formulation used. For its antioxidant and vitamin-like effects, it may take several days or even weeks of consistent dosing to notice a measurable difference in wellbeing. For its neuromuscular effects, the onset of action is much faster, typically occurring within 1 to 2 hours after an oral dose. Peak concentrations in the blood are usually reached within 3 hours. If you do not notice any improvement in your symptoms after two weeks of therapy, contact your healthcare provider to evaluate your treatment plan.
You should not stop taking Astragalus Propinquus Root suddenly without first consulting your healthcare provider, especially if you have been taking it for a long time. While it is not known to cause a traditional physical addiction, stopping it abruptly can cause the symptoms for which you are being treated to return quickly or even worsen. For example, if used for muscle modulation, you might experience a sudden increase in stiffness or spasms. Your doctor will likely recommend a gradual tapering of the dose to allow your body to adjust. Always follow the specific discontinuation schedule provided by your medical professional.
If you miss a dose of Astragalus Propinquus Root, take it as soon as you remember to maintain consistent levels in your system. However, if it is almost time for your next scheduled dose, skip the missed one and continue with your regular dosing schedule. Never take two doses at once to make up for a missed one, as this can lead to an overdose and increase the risk of dangerous side effects like muscle paralysis or respiratory distress. If you frequently forget your doses, consider using a pill organizer or setting a daily alarm. Consistent administration is key to the effectiveness of this medication.
There is currently no significant clinical evidence to suggest that Astragalus Propinquus Root causes weight gain in the majority of patients. In fact, some studies on its metabolic effects suggest it may help support healthy blood sugar levels, which is generally neutral or slightly beneficial for weight management. However, if you experience sudden weight gain or swelling (edema) in your legs or ankles, you should contact your doctor immediately. This could be a sign of a rare side effect affecting your kidneys or heart, rather than a direct effect on body fat. Always report significant changes in your weight to your healthcare team.
Astragalus Propinquus Root has several significant drug interactions that must be carefully managed. It can interfere with immunosuppressants, blood pressure medications, and drugs used to treat diabetes. Most importantly, it should never be taken with other neuromuscular blockers used during surgery, as the combination can be lethal. Because it affects the immune system and the neuromuscular junction, it is vital that your doctor knows about every other medication, herb, and supplement you are taking. They will check for potential interactions and may adjust your dosages to ensure that all your treatments work together safely.
Astragalus Propinquus Root is primarily available as a standardized botanical extract or as a component of specific allergenic testing panels, rather than a traditional 'brand-name' vs. 'generic' prescription drug. However, different manufacturers produce various standardized versions of the extract, which can vary in potency and quality. It is important to use the specific formulation recommended by your healthcare provider to ensure you are receiving the correct dose of active ingredients like Astragaloside IV. While less expensive versions may be available, they may not meet the same clinical standards for purity and concentration required for therapeutic use.
Other drugs with the same active ingredient (Astragalus Propinquus Root)